The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis

By Ramey Dena R.   Watson Douglas J.   Yu Chang   Bolognese James A.   Curtis Sean P.   Reicin Alise S.  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials

By Soni Paresh   Shell Briton   Cawkwell Gail   Li Chunming   Ma Hong  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1841-1851

Informa Healthcare

Access to resources Recommend Favorite

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs

By Watson D.J.   Bolognese J.A.   Yu C.   Krupa D.   Curtis S.  

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 1899-1908

Informa Healthcare

Access to resources Recommend Favorite

Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials

By Winblad Bengt   Black Sandra E.   Homma Akira   Schwam Elias M.   Moline Margaret   Xu Yikang   Perdomo Carlos A.   Swartz Jina   Albert Kenneth  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2577-2587

Informa Healthcare

Access to resources Recommend Favorite